Industry News
-
EQT Life Sciences leads USD 75 million Series B in Atalanta Therapeutics, a biotech firm developing treatments for epilepsy and Huntington’s disease
Jan 28 2025 -
Stealth faces another hurdle as FDA delays decision on Barth syndrome drug
Jan 24 2025 -
Biogen’s higher dose Spinraza under review by US and EU regulators
Jan 23 2025 -
Moderna Receives $590M from HHS to Advance Bird Flu Vaccines
Jan 23 2025 -
Key Opinion Leaders to Lead Investigator-Initiated Trial of Century Therapeutics’ CNTY-101 in Autoimmune Diseases
Jan 23 2025 -
Intellia Therapeutics Announces First Patient Dosed in the HAELO Phase 3 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema
Jan 22 2025 -
FDA gives Amylyx green light for phase 1 ALS trial after clinical hold
Jan 21 2025 -
CEPI provides $6.2m to push first mRNA-based Rift Valley fever vaccine into trial
Jan 21 2025 -
YolTech Therapeutics to Initiate a Clinical Trial for YOLT-204, a First-in-Class Bone Marrow-Targeted In Vivo Gene Editing Therapy for β-Thalassemia
Jan 20 2025